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In order to protect itself from a diverse set of environmental pathogens and toxins, the body has developed
a number of barrier mechanisms to limit the entry of potential hazards. Here, we compare two such barriers:
the gut immune barrier, which is the primary barrier against pathogens and toxins ingested in food, and the
blood-brain barrier, which protects the central nervous system from pathogens and toxins in the blood.
Although each barrier provides defense in very different environments, there are many similarities in their
mechanisms of action. In both cases, there is a physical barrier formed by a cellular layer that tightly regulates
the movement of ions, molecules, and cells between two tissue spaces. These barrier cells interact with
different cell types, which dynamically regulate their function, and with a different array of immune cells
that survey the physical barrier and provide innate and adaptive immunity.Introduction
The gut immune barrier (GIB) is the first line of defense against
any potential harmful agents that have been ingested in food.
The GIB has to constantly deal with innocuous food antigens
and with the microbial flora (collectively called the microbiota)
that are required for digestion and for conferring an initial protec-
tion against invading pathogens (Ley et al., 2006). Thus, the GIB
is equipped to interact with and tolerate the microbiota, induce
systemic tolerance to food antigens, and fight any possible
invader. Defects in these functions can lead to intestinal disor-
ders such as inflammatory bowel disease and irritable bowel
syndrome, food allergy or intolerance, and microbial infection.
The blood-brain barrier (BBB) is a specialized structure formed
by the blood vessels of the central nervous system (CNS). In
most tissues, blood vessels are leaky, allowing a relatively free
flow of molecules and ions from the blood into the tissue;
however, in the CNS, the blood vessels tightly restrict the flow
of blood-borne ions, molecules, and cells from entering the
neural tissue (Gloor et al., 2001; Rubin and Staddon, 1999; Zlo-
kovic, 2008). This BBB is a critical secondary barrier to protect
CNS tissue, which fails to regenerate after injury and disease.
Breakdown of the barrier occurs during many different neurolog-
ical diseases, including stroke, multiple sclerosis (MS), and
trauma and is an important component of the pathologies of
these disorders (Zlokovic, 2008). Evasion of the barrier by path-
ogens and infection of the CNS can lead to potentially fatal neu-
roinflammatory diseases including meningitis, encephalitis, or
focal abscesses. These infections can cause severe damage
to the CNS, which can lead to paralysis, dementia, and death.
In fact, bacterial meningitis is a top ten leading cause of bacterial
deaths in the world (Kim, 2008).
For each barrier, the body has therefore evolved a complex
set of cellular and molecular mechanisms to protect the
organism from toxins and infections. In each case, there is
a physical barrier formed by a cellular layer that tightly regulates722 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.the movement of ions, molecules, and cells between two tissue
spaces. For the GIB, this consists of gut epithelial cells, sepa-
rating the gut lumen from the internal space, whereas for the
BBB, this consists of CNS endothelial cells, which separate the
lumen of blood vessels from the CNS parenchyma. These barrier
cells are not isolated but interact with different cell types, which
dynamically regulate their function. For the GIB, the epithelial
cells are associated with enterochromaffin cells, goblet cells,
and Paneth cells and are in close contact with enteric glial cells
(Figure 1). For the BBB capillaries, pericytes are situated on the
abulimnal surface of the endothelial tube, and this blood vessel is
surrounded by a basal lamina. Neural cells form intimate
contacts with the vessels, most noteably astrocytes, a glial cell
that extends long processes whose endfeet ensheath the
vessels (Figure 1). Each barrier also contains a different array
of immune cells that survey the physical barrier and provide
innate and adaptive immunity. Here, we compare and contrast
the different properties of the gut immune barrier and the
blood-brain barrier as well as themechanisms that specific path-
ogens have developed to evade them.
Physical Barrier: Mucous Layer and Glycocalyx
An important difference between the GIB and the BBB is the
microenvironment to which the two barriers are exposed.
Whereas the BBB is only occasionally exposed to microorgan-
isms, the GIB is constantly in contact with the microbiota,
much of which is beneficial to digestion and protection. Thus,
an important difference between the two barriers is that the
GIB is equipped with a mucous layer that forms a first layer of
protection between the gut and the external world by physically
separating the microbiota from the epithelial barrier.
The mucus layer is like a mesh of networking fibers made
primarily of mucins, glycoproteins, and lipids that allows the
passage of definite-size molecules (Neutra et al., 1996) and
excludes bacteria from contacting the epithelial barrier. It is
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Figure 1. The Gut Immune and Blood-Brain
Barrier
The GIB is composed of amucus layer and a phys-
ical barrier. This is composed by epithelial cells,
enterochromaffin cells (ECCs), and Paneth cells.
ECCs release neuroimmunomodulatory mediators
such as serotonin (5-HT). Paneth cells release anti-
microbial peptides. A rim of tight junctions seals
the epithelial barrier and controls the paracellular
route of solutes, nutrients, and ions. Within the
epithelial barrier, immune cells such as intraepithe-
lial lymphocytes (primarily gdT cells) and CX3CR1
+
dendritic cells (DCs) are scattered. gd T cells
release antimicrobial peptides after epithelial
barrier disruption, whereas DCs can actively
participate in bacterial handling and activate
Th17 cells. DCs have also been shown to enter
the luminal side after bacterial infection. Below
the basal membrane, blood vessels are found
that are ensheathed by glial cells. The latter are
also in contact with epithelial cells and preserve barrier integrity via the release of S-nitrosoglutathione (GSNO). In the lamina propria (LP), other immune cells
are found, such as NKp46+RORgt cells, that release IL-22 in response to bacteria andmacrophages that are ‘‘inflammatory anergic’’ but that can still kill bacteria.
Another population of CD103+ DCs can also be found in the LP that induces the differentiation of Treg cells after migration to the mesenteric lymph nodes (MLN).
Plasma cells (PCs) can release IgA that can serve for immune exclusion and anchorage of commensal bacteria to mucus. Mast cells are a link between the gut
immune system and the brain as they can respond to and release neurotransmitters and immunemediators. In contrast, the properties of the BBB aremanifested
by CNS endothelial cells (blue), which form the walls of the blood vessels. These cells are held together by tight junctions creating a paracellular barrier and lack
transcytotic vesicles, creating a transcellular barrier. These cells also express a series of transporters, to both efflux a variety of lipophillic molecules and to deliver
specific nutrients to the CNS. The vascular endothelial cells are associated with pericytes (red), which together are surrounded by a basal lamina. In addition,
different immune cells, including perivascular macrophages andmast cells, are associated with the vessels (not depicted). Astrocytes send out processes whose
endfeet (green) ensheath the vessels. Interactions between endothelial cells and astrocytes, pericytes, and other neural and immune cells regulate the properties
of the BBB.composed of two fractions: a viscous, loose luminal gel and an
epithelium-adherent firm fraction that are extensively reviewed
elsewhere (Kelly et al., 2007; Linden et al., 2008; Macfarlane
andDillon, 2007; Sonnenburg et al., 2004). The firmmucous layer
constitutes the epithelial cell-associated glycocalyx where
mucins are found in their membrane-bound form. In the mouse,
this capacity is dependent on the expression of mucin-2 (muc)2
(Johansson et al., 2008). The loose mucous layer is formed by
soluble mucins that are released primarily by goblet cells that
are interspersed between epithelial cells (Linden et al., 2008).
This layer is exploited by the microorganisms to form a biofilm
that allows their growth and prevents their washout with the
luminal content, due to intestinal peristalsis (Macfarlane and Dil-
lon, 2007). Some bacterial species digest mucous components
and can be found also embedded in the mucus. The thickness
and composition of the mucous layer vary between the different
portions of the gastrointestinal tract (Atuma et al., 2001; Robbe
et al., 2004) and is dependent on the density of the microbiota,
being thicker where the microbiota is more abundant. Hence,
the mucous layer serves the dual function of physically sepa-
rating the bacteria from the epithelial barrier and of providing
an anchorage system for their growth.
Although the BBB does not contain a mucous layer per se, the
luminal surface of the endothelial cells is covered by a complex
glycocalyx, a dense layer of negatively charged carbohydrates
(Van Teeffelen et al., 2007). The glycocalyx lines the vascular
wall in all tissues, and it remains to be determined whether the
glycocalyx at the BBB has specific properties to protect the
CNS. The vascular glycocalyx has been shown to regulate
vascular homeostasis, protect the vascular wall from shear
stress, and modulate its interaction with blood cells (Van Teeffe-
len et al., 2007). Furthermore, the glycocalyx has been proposed
to act as a molecular sieve to block interaction of large blood-
borne molecules with the vascular wall (Vink and Duling, 1996,2000). As with the mucus layer, specific pathogens including
Haemophilus somnus, can bind to the glycocalyx and use it to
anchor to CNS endothelial cells (Behling-Kelly et al., 2006).
Cellular Barrier
Each barrier not only provides protection from invading patho-
gens, but is also important to control the microenvironment of
the tissue and, therefore, tightly regulates the movement of
molecules and ions between the cellular spaces. For the gut,
this is important to regulate nutrients, water, and salt absorption
and resorption into the digestive tract. For the CNS, this is impor-
tant because neural activity relies on precise cellular ion concen-
trations and the BBB separates the neural tissue from the ionic
fluctuations in the blood. Crucial to this tight regulation are the
barrier properties of the epithelial and endothelial cell layers.
A fundamental difference between the GIB and the BBB is the
origin of the cell types that form the barrier. In the gut, the epithe-
lial cells are endodermal in origin, whereas in the CNS, the endo-
thelial cells are mesodermal in origin. This difference stems from
the fact that gut epithelia protects organisms from external
hazards, whereas the BBB protects the CNS from hazards that
are within the organism. Despite this difference, a striking obser-
vation is that CNS endothelial cells, but not endothelial cells in
non-neural tissues, resemble epithelial cells in that they are
held together by tight junctions that polarize the cells to form
distinct apical and basolateral membrane compartments (Zlo-
kovic, 2008). Interestingly, mesodermal-to-epithelial cellular
transitions, and vice versa, are important events that occur
during development of different tissues and also the pathogen-
esis of cancer (Acloque et al., 2009).
Paracellular Junctions
Gut epithelial cells are sealed with each other by a circular rim
of tight junctions (TJ). TJs are formed by integral membraneImmunity 31, November 20, 2009 ª2009 Elsevier Inc. 723
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Reviewproteins called Occludin, Junctional adhesion molecule (JAM),
and Claudins and by cytoplasmic proteins connecting the TJ
with the cytoskeleton (Zonula occludens [ZO]-1, ZO-2, ZO-3,
7H6, and Cingulin). TJs do not form impermeable seals but
control the paracellular route of solutes by allowing the absorp-
tion of essential nutrients via the formation of a dynamic structure
that is modulated by pharmacological, physiological, and patho-
logical stimuli (reviewed in Shen and Turner, 2006). Mutagenesis
studies of Claudin family molecules suggest that specific amino
acid residues in the first extracellular domain of these tetraspa-
nins determines the size and charge selectivity of tight junction
pores (Colegio et al., 2003). In the GIB, Claudin 1, -4, -5, -7,
and -8 are most represented (Zeissig et al., 2007). TJs are not
static under steady state and the proteins are continuously dis-
placed and substituted with different kinetics according to the
analyzed TJ protein and physiological setting (Shen et al., 2008).
Endothelial cells in the brain, unlike endothelial cells in other
tissues, are coupled by ultrastructural tight junctions (Ballabh
et al., 2004; Gloor et al., 2001; Rubin and Staddon, 1999). The
molecular composition of BBB endothelial tight junctions shows
remarkable similarities to those in epithelial cells in that they are
formed by strands of Occludin, JAM, and Claudin molecules that
are linked to the cytoskeleton by Zonula Occludens (Hirase et al.,
1997; Morita et al., 1999; Nitta et al., 2003). Claudin 5 is critical to
BBB formation, as Claudin 5-deficient mice show a size selective
leakage of the BBB, whereas Occludin may specifically regulate
calcium flux between the blood and the brain because Occludin
deficient mice still form high-resistance junctions but have calci-
fication of the CNS (Nitta et al., 2003; Saitou et al., 2000). Claudin
1, -3, and -12 have also been identified at the BBB (Liebner et al.,
2008; Mark and Davis, 2002; Nitta et al., 2003; Wolburg et al.,
2003).
The tight junctions that form the paracellular barrier at the GIB
and BBB display remarkable molecular similarities, and the
specific claudin family members may be important for deter-
mining the permeability in each tissue. Moreover, downregula-
tion or redistribution of TJ proteins are observed under patholog-
ical conditions in which the barriers are disrupted, including
inflammatory bowel disease (IBD) (Turksen and Troy, 2004; Zeis-
sig et al., 2007) and irritable bowel syndrome (IBS) (Dunlop et al.,
2006; Spiller, 2008) for the GIB, and stroke (Sandoval and Witt,
2008) and MS (Correale and Villa, 2007) for the BBB.
Transcellular Barriers
The epithelial and endothelial cells also contain barrier mecha-
nisms that regulate themovement of molecules and ions through
the cell layers. Although the paraceullular barrier properties of
the GIB are quite conserved throughout the whole intestine,
transcellular barrier properties of the GIB differ according to
the section of the intestine that is considered. For instance, the
small intestine is primarily devoted to the degradation and
absorption of food. This is achieved via the vagination of the
mucosa to form villi that increase the surface of exposure to
nutrients. In addition, the apical face of small intestinal epithelial
cells forms a brush border consisting of microvilli that are
specialized for the digestion and absorption function and further
increases the absorption area. Food antigens are internalized
principally via endocytosis (Weiner, 1988), and nutrient sensing
results in the activation of the enteric neuronal pathways and724 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.the regulation of food intake (Raybould, 2008). The large intestine
is involved in the absorption of water and salts and in the diges-
tion of complex molecules (that is accomplished via the symbi-
osis with the microbiota). For this reason, as mentioned above,
the colon GIB is equipped with a thicker layer of mucus (Atuma
et al., 2001; Robbe et al., 2004). It is important to mention that
specialized epithelial cells, called M cells, can also be found in
the epithelium of the small and large intestine (Jang et al.,
2004). These cells lack an organized brush border and are
more easily approached by bacteria and toxins. A possible role
of M cells in the internalization of food antigens remains to be
established.
CNS endothelial cells contain a variety of specialized proper-
ties to tightly regulate transcellular passage of molecules and
ion. CNS endothelial cells contain fewer transcytotic vesicles
than endothelial cells in other tissues, thus limiting the transcel-
lular passage of hydrophilic molecules and ions from the blood to
the brain (Ballabh et al., 2004; Gloor et al., 2001; Rubin and Stad-
don, 1999). In addition, CNS endothelial cells express a series
of efflux transporters, including P-glycoprotein, which are able
to transport a variety of lipophilic molecules that are able to
passively diffuse from the blood into the brain, through the endo-
thelial lipid membranes, and back to the blood (Schinkel et al.,
1994; Schinkel et al., 1996). Whereas these properties allow
CNS endothelial cells to form a transcellular barrier, these cells
also express a variety of transporters to deliver specific nutrients
into the brain, including glucose, amino acids, and vitamins (Zlo-
kovic, 2008). Thus, CNS endothelial cells are simultaneously able
to exclude potential toxins and deliver specific nutrients into the
neural tissue. For both barriers, the combination of paracellular
tight junctions and transcellular transport properties allow the
cell layers to tightly regulate the movement of molecules and
ions between the two tissue spaces.
Regulation of the Barrier Properties
Another important similarity between the GIB and the BBB is that
barrier properties are regulated by interactions with other cells.
Although the properties of the BBB are manifested in the CNS
endothelial cells, transplantation studies have demonstrated
that they are not intrinsic to endothelial cells but induced by inter-
actions with neural tissue (Stewart and Wiley, 1981). Due to the
close association between astrocytes and endothelial cells,
extensive studies have examined the role of astrocytes in regu-
lating the properties of the BBB. Astrocyte feeder layers increase
the transcellular electrical resistance of endothelial monolayers
in vitro (Dehouck et al., 1990; Hayashi et al., 1997; Isobe et al.,
1996), and transplanted astrocytes are sufficient to induce
barrier properties in non-neural endothelial cells in vivo (Janzer
and Raff, 1987). Several molecules have been implicated in
mediating this response, including astrocyte src kinase SSeCKs
and secreted Angiotensin II (Lee et al., 2003; Wosik et al., 2007).
These studies have led to a two-step model for BBB formation in
which angiogenesis in the CNS proceeds by the same mecha-
nism as angiogenesis in other tissues, with the formation of leaky
vessels, which are then induced to form the BBB by interactions
with astrocytes. Several studies, however, have identified that
BBB properties in CNS endothelial cells are present during
development prior to astrocyte generation (Bauer et al., 1993;
Ek et al., 2006), and in vitro studies have implicated both neural
Immunity
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endothelial cells (Dohgu et al., 2005; Hori et al., 2004; Weidenfel-
ler et al., 2007). Moreover, recent work has demonstrated that
neural stem cell-derived Wnt-b-catenin signaling is required for
CNS angiogenesis, but not angiogenesis in non-neural tissue,
and also induces BBB-specific transporter expression and tight
junction formation (Daneman et al., 2009; Liebner et al., 2008;
Stenman et al., 2008). This suggests that angiogenesis and
BBB induction may be tightly linked. If BBB properties are
induced during angiogenesis, what role do astrocytes play in
regulating BBB function? To answer this question it is important
to identify whether barrier properties in CNS endothelial cells are
induced by a single induction event during development or need
to be maintained by constant signaling throughout life. Evidence
suggests that BBB regulation may involve a complex combina-
tion of bothmechanisms. For instance, when purified CNS endo-
thelial cells are grown in culture without neural tissue, they
express many BBB-specific genes, including molecular trans-
porters and tight junction molecules, but fail to form high-resis-
tance junctions and lack polarity (Rubin et al., 1991; Weidenfeller
et al., 2007). These results suggest that certain aspects of BBB-
specific gene expression may be induced during angiogenesis,
but function of the barrier may need to be regulated dynamically
throughout life by interaction with astrocytes as well as pericytes
and different neural and immune cells.
For the GIB, enteric glial cells that are morphologically very
similar to astrocytes, with which they share many common
markers and functions, dynamically regulate the permeability
of the barrier. Besides protecting the enteric neurons, glial cells
participate to preserve intestinal epithelial barrier integrity. In
analogy with astrocytes in BBB function, enteric glial cells,
whose projections come very close to epithelial cells (<1 mm)
(Neunlist et al., 2007) and blood capillaries (Hanani and Reichen-
bach, 1994), release soluble factors that control paracellular
permeability via a direct action on TJ proteins (Neunlist et al.,
2008). One of these factors is S-nitrosoglutathione (Savidge
et al., 2007). Conditional ablation of enteric glial cells results in
an increase in vascular and paracellular permeability that leads
to lethal intestinal disease (Bush et al., 1998; Cornet et al.,
2001). Concomitant administration of S-nitrosoglutathione
during enteric glial cell ablation inhibits the increased intestinal
epithelial barrier permeability and protects mice from colitis
(Savidge et al., 2007). Restored barrier function is associated
with an increase of TJ protein Occludin and ZO-1 expression
(Savidge et al., 2007). Hence, glial cells play a fundamental role
in intestinal epithelial barrier integrity.
The GIB epithelial barrier also contains enterochromaffin cells
that represent the most abundant neuroendocrine cells in the
gut. These cells have a triangular shape and are interspersed
among epithelial cells. They are considered to be the first
‘‘sensors’’ of the luminal content, which they reach with a very
thin luminal extension. Luminal stimuli activate enterochromaffin
cells to release serotonin (5-hydroxytryptamine, 5-HT) (Spiller,
2008). Ninety-five percent of all gut serotonin is produced by
enterochromaffin cells. Serotonin has a variety of targets, such
as neighboring epithelial cells, neuronal afferents in the lamina
propria, and immune cells. The outcome is activation of gut
contractility and motility, leading to diarrhea and vomiting, which
are primitive mechanisms of protection against infection. Duringinfection, the number of enterochromaffin cells increases via
a T cell-dependent mechanism (Wang et al., 2007). Th2, but
not Th1, T cells are involved in enterochromaffin cell hyperplasia
(Motomura et al., 2008). Serotonin has been shown to be
involved also in the control of epithelial permeability, suggesting
that enterochromaffin cells may participate in controlling GIB
permeability (Yamada et al., 2003).
Further research identifying the molecules that regulate each
barrier during health and disease will increase our understanding
of the similarities and differences between barriers throughout
the body.
Immune Barrier
Each barrier is important to regulate tissue immunity for two
reasons. First, each cellular barrier regulates the movement of
immune cells in order to maintain the appropriate contingent in
each separated tissue space in order to fight infections but limit
potentially damaging inflammation. Second, in both cases,
immune cells are associated with the physical barrier to provide
immunity at entry sites. The GIB epithelial cells are associated
with intraepithelial lymphocytes and dendritic cells (DCs),
whereas BBB endothelial cells are associated with perivascular
macrophages and mast cells (Ibrahim et al., 1980; Williams
et al., 2001). Both barriers are reinforced by immune cells that
are located just underneath the physical barrier. The lamina
propria of the gut contains lymphocytes, plasma cells, DCs,
macrophages, mast cells, and NK cells, whereas the CNS
contains primarily microglial cells (Streit et al., 2005). The
different immune cell composition leads to different adaptive
immune responses between the two tissues.
Regulation of Immune Cell Migration
Both barriers regulate the movement of immune cells between
two tissue spaces; however, there is a difference in the direction-
ality of this regulation. For the GIB, immune cells originate from
the abluminal tissue (lamina propria) and their movement into
the gut lumen is regulated. For the BBB, the immune cells origi-
nate in the luminal space (blood) and their movement is regulated
into the abluminal CNS tissue. One important similarity is that
under steady-state the two barriers allow only very limited
passage of immune cells for different reasons. The GIB has to
preserve the homeostasis of the microbiota and limits its
encounter with immune cells, whereas the BBB has to preserve
the homeostasis of the brain and limits the passage of immune
cells, especially lymphocytes, leading to minimal immune sur-
veillance of the CNS. In both cases, massive infiltration of
immune cells is observed in pathological conditions.
The CNS has been considered an ‘‘immune-privileged site’’
due to a lack of graft rejection when tissue is transplanted into
the CNS. This ‘‘privilege’’ is due to a lack of draining lymphatics,
specific properties of local antigen presenting cells, and an
almost complete lack of lymphocytes, which are impeded entry
by the BBB (Carson et al., 2006). Understanding the entry of
immune cells across barriers is important not only for under-
standing tissue immune function, but also understanding how
pathogens cross barriers because bacteria, fungi, and viruses
can cross the BBB either by mimicking immune cells or by
infecting migrating immune cells. For vasculature, leukocyte
migration through blood vessels involves a rolling adhesion toImmunity 31, November 20, 2009 ª2009 Elsevier Inc. 725
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and finally, migration either between endothelial cells or through
endothelial vesicular compartments. In general, weak binding is
initiated between endothelial selectin molecules and leuckocyte
carbohydrates, and tight adhesions are solidified through
binding of leukocyte integrins with endothelial cell immunoglobin
superfamily members such as ICAM1 and VCAM (Huang et al.,
2006). P-selectin and ICAM1 exhibit lower resting expression
in brain vessels than peripheral vessels, which may account for
the low level of CNS immune surveillance (Aird, 2007; Henninger
et al., 1997). These molecules, however, have been shown to be
upregulated during pathological conditions, including infection,
autoimmune disease, or stroke (Engelhardt, 2008; Huang et al.,
2006). In addition, passive transfer of T cells activated in vitro,
but not resting T cells, can cross an intact BBB, suggesting
that immune surveillance can occur in healthy individuals (Engel-
hardt, 2006; Hickey et al., 1991). These results suggest that
T cells activated outside the immune system can cross the
resting BBB, but unactivated T cells can only enter the CNS
during neuroinflammatory process such as those that occur in
patients with MS.
Recently, the gut has also been regarded as an ‘‘immune-priv-
ileged site,’’ but not in the conventional sense. This is due to the
necessity of the immune system to avoid inflammation in
response to microbial-associated inflammatory stimuli and to
induce tolerance toward food antigens (Iweala and Nagler,
2006). Unlike the BBB, in the gut, immune privilege is not
intended to control the entrance of potentially autoreactive
adaptive immune cells. In contrast, adaptive immune cells, pri-
marily T regulatory cells, IgA-secreting plasma cells, gd T cells,
and Th17 cells, are present also at steady state and participate
to preserve gut homeostasis. T regulatory cells protect the
host from tissue damage due to microbial-derived inflammation
and mediate food tolerance (Belkaid and Tarbell, 2009). Th17
cells and gd T cells instead offer a first line of protection toward
commensal bacteria and, together with NKp46+ cells, allow
epithelial cell repair (see below). In order to be recruited into
the intestine, lymphocytes express gut homing receptors that
are imprinted during their activation by mucosal DCs (Mora
et al., 2008). A different combination of gut-homing receptors
is required to home to the small or large intestine: coexpression
of a4b7 and CCR9 allows recruitment into the small intestine,
whereas CCR10 directs lymphocytes to the large intestines
(Macpherson et al., 2008).
Gut resident immune cells are set to minimize microbial-
derived inflammation and participate in epithelial repair, but still
retain their microbicidal activity. Further, in the gut, it is neces-
sary to discriminate between dangerous and harmless microor-
ganisms. This control seems to be carried out primarily by
epithelial cells for their capacity to distinguish between invasive
and noninvasive bacteria. This is due partly to the polarized
expression of pattern recognition receptors that recognize com-
mon microbial structures either on the basolateral membrane or
intracellularly, and partly to the differential response obtained
when apical or basolateral receptors are engaged (Lee et al.,
2006; Rescigno et al., 2008). As long as the bacteria are kept
outside the physical barrier, there is no initiation of inflammation.
However, if a bug succeeds to cross the epithelial cells (a char-
acteristic normally associated with pathogenicity), a danger726 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.signal is released by the epithelial cells that leads to the recruit-
ment of inflammatory cells, including neutrophils andmonocytes
(Sansonetti, 2004), and to the induction of adaptive immunity.
Recruited neutrophils (Chadwick et al., 1988) and, recently,
also DCs, (Arques et al., 2009) are able to cross the epithelial
barrier where they can potentially attack the bacteria and limit
their crossing the epithelial barrier. Invasive bacteria are then
handled by the resident immune cells and by the recruited
phagocytes that recognize the invaders as potentially dangerous
and proceed to their elimination. This is, however, associated
with inflammation and tissue damage that, if protracted over
time, can lead to chronic inflammation and the development of
inflammatory disorders.
Barrier-Associated Immune Cells
GIB-associated immune cells (Figure 1) participate in the
homeostasis of the gut to fight potential invaders but also to
sense the external world. DCs, for instance, do not play simply
a passive role, but actively participate in bacterial internalization
across the epithelium and may serve as a tool to ‘‘sense’’ the
external world (Rescigno et al., 2001). DCs express TJ proteins
and can intercalate between epithelial cells for direct uptake of
antigens across the intestinal lumen (Rescigno et al., 2001).
These cells express CX3CR1 (Niess et al., 2005) and also have
the capacity to induce Th17 cell type of responses (Atarashi
et al., 2008; Denning et al., 2007). Th17 cells can confer protec-
tion toward a variety of bacteria and fungi (Dubin and Kolls,
2008). Another subset of lamina propria DCs expressing the
CD103 marker are instead involved in driving the development
of T regulatory cells (Sun et al., 2007). CD103+ DCs cells are
implicated in the development of tolerance to orally ingested
antigens. Macrophages isolated from the lamina propria display
reduced capacity to induce inflammation in response to micro-
bial stimulation, but are fully capable of killing bacteria (reviewed
in Kelsall, 2008). The intestinal barrier is also patrolled by intrae-
pithelial T cells. The most abundant intestinal intraepithelial
lymphocytes bear the gd T cell receptor (Kunisawa et al.,
2007). gd T cells promote repair of injured gut epithelia (Komano
et al., 1995). gd T cells play a major role in limiting the entrance of
commensal bacteria after epithelial injury via the release of anti-
microbial factors (Ismail et al., 2009). This response is mostly
induced by the microbiota because in its absence (germ-free
mice), the induction of the majority of genes related to inflamma-
tion and to the antimicrobial response is drastically reduced after
intestinal epithelial disruption (Ismail et al., 2009).
Classical NK cells develop from hematopoietic stem cells in
the bone marrow and thymus. These cells seed peripheral
organs such as the spleen, lung, liver, and lymph nodes (Di Santo
and Vosshenrich, 2006). Although NK cells have long been
considered to be proinflammatory killer cells, recent evidence
has shown the existence of subtypes of NK cells with distinct
immunoregulatory function (Maroof et al., 2008). In the gut, one
of these subsets (NKp46+RORgt+ cells) has been described
that displays GIB protective function. These cells release IL-22
which is required both for epithelial cell repair and antibacterial
activity (Cella et al., 2009; Luci et al., 2009; Sanos et al., 2009;
Satoh-Takayama et al., 2008; Vivier et al., 2009; Zheng et al.,
2008). Differently from classical NK cells, NKp46+RORgt+ cells
are unable to release the cytokines IFN-g, IL-12, or IL-18, thus
Immunity
Reviewlimiting the inflammatory reaction. Also, plasma cells are found in
the lamina propria. These cells release, primarily, Immunoglob-
ulin (Ig)-A that participates to mucosal defense as they
immune-exclude IgA-coated bacteria (Cerutti and Rescigno,
2008). IgA can also serve to anchor commensal bacteria to the
mucus and allow their colonization (Corthesy, 2007).
The GIB is also reinforced by a chemical component. This
includes antimicrobial peptides such as defensins, angiogenins,
defensins-like peptides that are released by enterocytes, or by
Paneth cells that reside at the base of the crypts of Lieberkhun.
The expression of antimicrobial peptides is regulated by the
presence of indigenous microorganisms (Cash et al., 2006), via
different mechanisms according to the class of peptides that
are analyzed. The expression of a-defensins is controlled by
the intracellular pattern recognition receptor belonging to the
Nucleotide oligomerization domain (NOD)-2 (Kobayashi et al.,
2005), whereas RegIIIg, RegIIIg, CRP-ductin, and RELMb are
regulated via the MyD88-dependent Toll-like receptor pathway
(Vaishnava et al., 2008). Hence, commensals can regulate the
host-microbial homeostasis at mucosal surfaces via the activa-
tion of pattern recognition receptors in epithelial and Paneth cells
and the release of antimicrobial peptides. These peptides limit
the translocation and propagation of microbes from mucosal
surfaces to peripheral lymphoid tissues, thus actively partici-
pating to barrier function (Vaishnava et al., 2008).
At the BBB, perivascular macrophages reside on the paren-
chymal side of the endothelial cells between the vessel and
astrocyte endfeet (Williams et al., 2001). These cells are derived
from peripheral monocytes, and human transplantation studies
have demonstrated that they are steadily replaced from hema-
togenous populations (Unger et al., 1993). Moreover, rodent
bone marrow chimera studies have shown an 80% turnover of
perivascular macrophages in 3 months (Vass et al., 1993),
demonstrating a remarkable capability of these cells to cross
an intact BBB. Perivascular macrophages have been shown
to play a role in the innate immune response in that they phago-
cytose cellular debris and foreign particles (Williams et al.,
2001). Studies have utilized intraventricular injection of manno-
sylated clodronate liposomes that completely deplete perivas-
cular and meningeal macrophages from the CNS to study their
role in infection. For pneumococcal meningitis infections, this
resulted in an increased illness, higher bacterial loads in cere-
brospinal fluid (CSF) and blood, and a decreased flux of leuko-
cytes into CSF (Polfliet et al., 2001). In addition, perivascular
macrophages can act as antigen-presenting cells (APCs) to
initiate an adaptive immune response in certain pathological
conditions (Hickey and Kimura, 1988). Taken together, these
results suggest that perivascular macrophages play an impor-
tant role in innate and adaptive immune response, and their
perivascular localization provides an immune component at
the BBB to further protect the CNS from invasion of pathogens.
Although perivascular macrophages are an important element
of the BBB, because of their frequent migration across the
endothelial monolayer, these cells can also be harnessed to
act as shuttles for pathogens to enter the CNS (Williams and
Blakemore, 1990). This ‘‘Trojan horse’’ mechanism has been
suggested for HIV and Cryptococcus neoformans infection of
the CNS (Buckner et al., 2006; Charlier et al., 2009). For
instance, in rodent infection studies, bone marrow-derivedmonocytes infected in vitro with C. neoformans had a 3.9-fold
increased CNS infection rate compared to addition of free yeast
(Charlier et al., 2009).
Microglial cells are monocyte-derived CNS resident cells that
differ from perivascular macrophages in their localization,
morphology, immunophenotype, and function. Microglial cell
bodies are not intimately associatedwith vessels but are situated
throughout the CNS parenchyma. These cells are highly ramified
and contain cellular processes that touch the vasculature and
can regulate BBB function. Microgliosis is a common feature
of all CNS injury and disease and involves microglial cell division,
hypertrophy, and changes in immunophenotype and secretory
activity (Streit et al., 2005). Parabiosis studies have demon-
strated that microglial cells are not recruited from hematogenous
populations during microgliosis but through cell division within
the CNS parenchyma (Ajami et al., 2007). Microglial cells act
as a part of the innate immune response eliminating microorgan-
isms and promoting wound healing by acting as tissue-specific
phagocyte of foreign particles, macromolecules, and debris as
well as producing growth factors and extracellular matrix (Streit
et al., 2005). In addition, microglia can act as APCs to initiate an
adaptive immune response. Therefore, microglia are CNS resi-
dent monocyte-derived cells that modulate immune responses
in the CNS parenchyma.
Mast cells are present at both the GIB and the BBB, and they
respond to and release mediators of both the nervous and
immune system (Marshall, 2004). In the gut, mast cells are stra-
tegically located in proximity to blood vessels and enteric nerve
endings (Stead et al., 1987) and are efficiently activated by
a variety of mechanisms in response to bacterial or parasitic
infection (Dawicki and Marshall, 2007). They release a series of
mediators aimed at the recruitment of inflammatory cells that
can have an important effect also on epithelial barrier perme-
ability. Tryptase, for instance, can activate PAR-2 receptors on
epithelial cells and increase epithelial permeability via modula-
tion of TJ proteins (Cenac et al., 2004). PAR-2 receptors are
also expressed on nerve endings, and their activation may
result in neurogenic inflammation (Steinhoff et al., 2000). Not
surprisingly, mast cell activation has been implicated in several
stress-related intestinal disorders, like ulcerative colitis (UC)
and IBS (Farhadi et al., 2007). Consistently, mice deficient in
mast cells display increased anxiety-like behavior, but the effect
on gut permeability or colitis has not been analyzed (Nautiyal
et al., 2008). In the CNS, mast cells are associated with vessels
in specific regions of the brains, most notably the dorsal thal-
amus and the circumventricular organs (Ibrahim et al., 1980).
They have the ability to degranulate, and vesicular contents
can be picked up by neurons (Wilhelm et al., 2005). However,
the role of mast cells in nervous system development and func-
tion or immunity is not fully understood.
Intestinal Disorders: Inflammatory Bowel Disease
and Irritable Bowel Syndrome
Given the important role of the GIB in controlling intestinal
homeostasis defects linked to any of the components of GIB
may participate to intestinal inflammatory disorders. IBD
comprises UC and Crohn’s disease (CD). CD is characterized
by discontinuous inflammation that can affect the terminal ileum
or the colon. The whole mucosal layers can be involved in theImmunity 31, November 20, 2009 ª2009 Elsevier Inc. 727
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ical examination. UC, by contrast, involves only the colon, and
the inflammation is restricted to the superficial mucosa. These
are multifactorial disorders with genetic and environmental
components. The involvement of bacteria in IBD development
has been demonstrated by the capacity of antibiotics to amelio-
rate the severity of the disease (Ewaschuk et al., 2006) and by
the genetic association of IBD with mutations in the genes
that encode CARD15 (NOD2) (Hampe et al., 2001; Hugot et al.,
2001; Ogura et al., 2001), CARD4 (NOD1) (McGovern et al.,
2005), or TLR4 (De Jager et al., 2007; Franchimont et al., 2004),
which are sensors of bacteria, or mutations in autophagy-related
genes that are important in innate defense (Hampe et al., 2007;
Saitoh et al., 2008). Although long sought after, a clear associa-
tion with any pathogenic bacteria has not, however, been
demonstrated in the etiology of IBD. By contrast, IBD patients
have been shown to immune-react to their autologous flora,
whereas normal individuals react only to the heterologous flora
(Duchmann et al., 1995). How these responses are initiated
and whether there is a primary defect in intestinal permeability
that allows entrance of otherwise excluded bacteria remains to
be established. Also, as the noninflammatory phenotype of
macrophages and DCs is conferred by the local microenviron-
ment, defects in this compartment compromise the homeostasis
of the gut via the inability of controlling the inflammatory potential
of immune cells (Iliev et al., 2009a, 2009b; Rimoldi et al., 2005;
Smythies et al., 2005). Another inflammatory disorder of the
gut that can be associated to GIB dysfunction is IBS. IBS is
a heterogeneous multifactorial disorder. IBS has been shown
to be related to psychological stress, presumably via the release
of corticotrophin-releasing hormone (CRH) (Fukudo, 2007). CRH
can activate immune cells and induces mast cell degranulation
and increased intestinal permeability (Wallon et al., 2008). This,
together with the observation that the number of mast cells is
increased in rectal biopsies from IBS patients independent of
their IBS subtypes (Lee et al., 2008), links mast cell activation
with IBS. It would be interesting to know whether defects asso-
ciated with BBB permeability can participate in gastrointestinal
disorders and vice-versa.
Neuroinflammation: Stroke and Multiple Sclerosis
Ischemic stroke is a debilitating disease resulting from the loss of
blood flow to specific regions of the CNS. This results in break-
down of the BBB and includes infiltration of leukcoytes and both
neutrophils and monocytes, but not lymphocytes, into the CNS
(Huang et al., 2006). Insights into the cellular and molecular
events that occur following stroke come from animal models of
middle cerebral artery occlusion. After occlusion, secretion of
the cytokines IL-1, IL-6, TNF-a, and TGF-b leads to an upregula-
tion of ICAM-1 and Selectins on the vascular endothelium, which
promotes leukcocyte migration across the BBB (Huang et al.,
2006). This neuroinflammation is important for the severity of
the disease because less damage is observed in P-selectin-defi-
cient mice, ICAM1-deficient mice, or after delivery of antibodies
against eithermolecule (Bowes et al., 1993; Connolly et al., 1996;
Mayadas et al., 1993).
MS is a T cell-mediated autoimmune disease which targets
myelin in the white matter of the CNS. In MS, lymphocytes enter
the CNS, both because of focal disruptions of the BBB, and728 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.because of increased leuckoycte adhesion molecules on the
inflamed BBB. In experimental autoimmune encephalitis (EAE),
the mouse model of MS, lymphocyte integrin a4b1 binding to
endothelial VCAM1 is critical for recruitment of inflammatory
cells to CNS (Baron et al., 1993; Yednock et al., 1992). Blocking
this interactionwithNatalizumab, an antibody against a4 integrin,
hasbeenbeneficial for limiting the symptomsassociatedwithMS
(Polman et al., 2006). ICAM1 is also upregulated on CNS vessels
during EAE, and ICAM1-deficient mice displayed reduced T cell
infiltration and attenuated symptoms following EAE induction
(Bullard et al., 2007; Steffen et al., 1994). In vitro coculture exper-
iments suggest that T cell interactions with VCAM1 are required
for firm adhesion to the endothelium and interactions with ICAM1
for transmigration (Engelhardt, 2006; Laschinger andEngelhardt,
2000; Lyck et al., 2003). In addition, the Ig superfamily adhesion
molecule ALCAM is upregulated on CNS endothelial cells in MS
lesions. ALCAMbinds to CD6 on T lymphocytes, B lymphocytes,
and monocytes, and ALCAM antibodies decreased the move-
ment of monocytes, B cells, and CD4+ T cells, but not CD8+
T cells acrossBBBmonolayer in vitro, anddecreased the severity
of EAE in vivo (Cayrol et al., 2008). In addition, monocyte infiltra-
tion into theCNS is important for thepathogenesis ofMS. Studies
have identified that migrating monocytes are induced by cyto-
kines from the inflamed BBB to form antigen-presenting DCs,
which can activate T cells (Bailey et al., 2007; Greter et al.,
2005; Ifergan et al., 2008). Monocyte-endothelial cell coculture
experiments have elucidated several steps in the mechanism
by which monocytes can passage through the BBB. Monocytes
can induce tissue plasminogen activator (tPA) release by CNS
endothelial cells, which activates ERK1 and ERK2 kinases and
which can lead to a degradation of the tight junction protein
Occludin (Reijerkerk et al., 2006, 2008).
These findings demonstrate that neuroinflammatory pro-
cesses can lead to a breakdown of the BBB and an increased
leukocyte migration into the CNS. This leukocyte infiltration
causes massive damage to the CNS, and thus, methods to
inhibit excess inflammation may prove vital for therapeutics for
these diseases. However, the death of Natalizumab-treated
patients because of the viral Progressive Multifocal Leukoence-
phalopathy (PML) highlights the importance of a basal level of
immune surveillance in clearing CNS pathogens (Engelhardt,
2008). Therefore, the BBB performs a crucial role in regulating
the degree of CNS immune surveillance.
Evasion of Barriers by Pathogens
Although the two barriers provide an effective obstacle, specific
pathogens, including bacteria, fungi, and viruses, have devel-
oped mechanisms that utilize cellular and molecular com-
ponents of the host immune system and/or the barriers them-
selves to gain access to the CNS. Methods of crossing the
barriers include transcellular passage through tight junctions,
paracellular passage in endosomal vesicles, and ‘‘Trojan horse’’
approaches by which invasive microorganisms infect bone
marrow-derived cells that can cross the barriers (Kim, 2008). In
addition pathogens themselves can alter the function of the
barrier and cross ‘‘leaky’’ barriers (Figure 2).
Although the major portal of entry for invasive pathogens
across the gut mucosa are the M cells that are interspersed in
the follicle-associated epithelium of Peyer’s Patches and
Immunity
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oped several strategies to invade theGIB. First, they can degrade
the mucous layer. Several microorganisms are equipped with
proteases and glycosidases able to digest the mucins (Crowther
et al., 1987; de Repentigny et al., 2000; Moncada et al., 2000).
Second, they have the capacity to penetrate the epithelial
barrier. This can be achieved via four alternative pathways (Fig-
ure 2). Bacteria such as Salmonella, Shigella, and Yersinia can
induce their own phagocytosis by epithelial cells (Cossart and
Sansonetti, 2004)—a characteristic that is conferred by type-
three secretion systems (a syringe-like apparatus that allows the
injection of virulence factors that induce cytoskeleton rearrange-
ments and bacterial engulfment) (Mueller et al., 2008); Microor-
ganisms can also be taken up directly by intraepithelial DCs
that are naturally phagocytic cells (Niess et al., 2005; Rescigno
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Figure 2. Mechanisms Developed by Bacteria to Cross the GIB or
the BBB
Bacteria have evolved strategies to degrade mucins and to cross the epithelial
barrier. Invasive bacteria can release proteases or glycopeptidases to
degrade mucins, which then allows them to penetrate the epithelial barrier.
Four alternative pathways have been described: Bacteria can target TJ
proteins either directly or via the release of toxins to disorganize TJ allowing
their penetration via the paracellular route. Bacteria can induce their own
phagocytosis by epithelial cells. Microorganisms can also be taken up directly
by intraepithelial DCs. Microorganisms such as viruses can exploit the
receptor-mediated endocytosis. In the CNS, pathogens, including viruses
and bacteria, can evade the BBB by paracellular movement through tight junc-
tions, or transcellular movement through the cells (often in membrane bound
vacuoles), or through a Trojan horse approach by infecting transmigrating
monocytes, or by eliciting a breakdown of the BBB, thus allowing free entry
into the CNS.et al., 2001) but that also have the ability to translocate tomesen-
teric lymph nodes for antigen presentation and T cell activation;
microorganisms such as C. difficile, B. fragilis, V.cholera, and
C. perfringens can target TJ proteins either directly or via the
release of elaborated toxins and disorganize TJ allowing their
penetration via the paracellular route (Berkes et al., 2003); and
finally, viruses can exploit receptor-mediated endocytosis in
epithelial cells and likely also DCs (Fleeton et al., 2004; Gastal-
delli et al., 2008; Turville et al., 2002). Once inside the host,
bacteria are attacked by first-line resident and recruited immune
cells that either release antimicrobial mediators or phagocytose
the microorganisms for their killing. However, several bacteria
have evolved strategies to evadephagocytic killing and to survive
within phagocytes. Phagocytes are motile cells and can be used
as ‘‘Trojan horses’’ to invade other organs such as the spleen
(Vazquez-Torres et al., 1999), liver, and eventually, the brain
(Buckner et al., 2006). It remains to be established whether the
lamina propria capillaries that are located just underneath the
basal membrane of epithelial cells have the capacity to impede
the entrance of microbes into the systemic circulation and
whether this barrier is evaded by invasive bacteria.
Infections are quite common, but why do we only see infec-
tions of the CNS in rare occasions? One factor is the magnitude
of bacteraemia. Similar blood amounts of Eschericia coli were
required for passage across the BBB in animals of different
ages suggesting a threshold level of bacteraemia must be
reached before crossing BBB (Kim et al., 1992). This has also
been shown for other pathogens including Streptococcus aga-
lactiae and Streptococcus pneumonia (Kim, 2008) and highlights
the importance of external barriers in limiting the serum amounts
of pathogens.
Studies have utilized cultured human brain microvascular
endothelial cells (HBMECs) to identify the mechanisms of BBB
transversal. Several pathogens, including Trypanosoma and
Borrelia, have been shown to cross the HBMECs through a para-
cellular route (Kim, 2008). Electron microscopy (EM) studies
demonstrate that Trypanosoma brucei gambiense and Borrelia
burgdorferi bind to endothelial cells at or near the tight junctions
(Grab et al., 2004, 2005), and passage of Trypanosoma brucei
gambiense through the endothelial cell layer causes a decrease
in transendothelial cell electrical resistance (Grab et al., 2004).
Furthemore, attachment of Borrelia causes an increase in
vascular matrix metalloproteinases expression (Grab et al.,
2005), which has been shown to degrade tight junctions allowing
for passage of monocytes (Reijerkerk et al., 2006). Neisseria
meningitides also cross endothelial cells through parecellular
junctions. These bacteria possess type IV pili, which bind
human brain endothelial cells and recruit the Par3-Par6-PKCz
polarity complexes away from tight junctions to bacterial-cell
interfaces. This process leads to disruption of paracellular junc-
tions and allows access of the pathogen to the CNS (Coureuil
et al., 2009).
In addition, pathogens including E. Coli, S agalactiae, S. pneu-
monia, Neisseria meningititis, Candida albicans, and C. neofor-
mans can cross the BBB through a transcellular route (Kim,
2008). EM studies have visualized E. coli in membrane-bound
vacuoles within HBMECs, suggesting a transcellular route of
BBB crossing (Prasadarao et al., 1999). This passage involves
binding to endothelial cell surface, alterations in endothelialImmunity 31, November 20, 2009 ª2009 Elsevier Inc. 729
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bacteria, and traversal through endothelial cells in vacuoleswhile
avoiding lysosomal fusion. Interestingly, K1 E. coli have been
shown to adhere to HBMECS, but not endothelial cells derived
from non-neural tissues, suggesting that there may specific tar-
geting of this strain to neural tissue (Kim, 2008). Mutagensis
screening has identified several E. coli genes that affect its
passage across the BBB into the CNS. Specifically the K1 variant
of E. coli causes meningitis and strains deleted for ompa, fimh,
ibea, ibeb, ibet, yijp, asla, and cnf1 are less likely to cross BBB
(Hoffman et al., 2000; Huang et al., 1995, 1999; Khan et al.,
2007; Teng et al., 2005, 2006; Wang et al., 1999; Zou et al.,
2007). Several details of the molecular mechanism for E. coli
binding to HBMECs have been elucidated. For instance, the
outer membrane protein OmpA binds to GlcNAc residues on
endothelial surface glycoproteins including gp96, and also
increase the expression of type 1 fimbriae, which bind CD48
on endothelial cells (Khan et al., 2007; Prasadarao et al., 2003;
Teng et al., 2006). Invasion of endothelial cells requires IbeA
proteins that bind PSF and activate cytoskeletal changes in
a process that ‘‘zipper’’ the bacteria (Zou et al., 2007). CNF1 is
a bacterial ab toxin that aids in the traversal through endothelial
cells by activation of RhoGTPases (Chung et al., 2003). Interest-
ingly, CNF1 acts through the laminin receptor on endothelial
cells, which is also a cellular target for dengue virus, adeno-asso-
ciated virus, prion protein, S pneumonaie, N. meningitides, and
Haemophilus influenzae (Kim, 2008; Orihuela et al., 2009). This
suggests that evolutionary diverse pathogens have developed
similar methods to cross the BBB.
HIV may be the best example of a pathogen that crosses the
BBB by a Trojan horse mechanism because the virus infects
monocytes that repopulate perivascular macrophages (Buckner
et al., 2006). HIV has been shown to infect monocytes by interac-
tions between viral envelope glycoproteins and monocyte CCR5
receptors (Deng et al., 1996). In addition, HIV infection of mono-
cyte cells increases surface expression of LFA-1, an ICAM1
ligand that increases likelihood of adhesion to CNS endothelial
cells (Stent and Crowe, 1997). Once in the CNS, monocytes
can spread the virus to microglia, perivascular macrophages,
and astrocytes, creating a reservoir of the virus. Patients with
HIV have serious CNS complications, including encephalitis
and dementia, which are characterized by leukocyte infiltration
into the CNS, microglial activation, BBB disruption, and ulti-
mately damage to neurons (Buckner et al., 2006). These symp-
toms are due to direct infection of the CNS, as parenchymal viral
reservoirs are observed in patients. In fact, the prevalence of
neurological symptoms in HIV patients is increasing because
as new therapeutics extend lifespan by reducing viral loads in
non-CNS tissue, these same therapeutics fail to cross the BBB
and treat HIV reservoirs in the CNS.
In addition, pathogens can gain access to the CNS by disrupt-
ing the BBB. For instance, the HIV envelope glycoprotein gp120
has been shown to increase BBB permeability through interac-
tions with endothelial transmembrane coreceptors CCR5 and
CXCR4 (Kanmogne et al., 2007).
Concluding Comments
Although the GIB and BBB protect different tissues, these
barriers have developed many similar mechanisms to maintain730 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.tissue homeostasis. Both barriers consist of a cellular layer
that forms a physical barrier and a different array of immune cells
that provide further protection. In each case, these barriers are
regulated by interactions with neighboring cells and environ-
mental stimuli, and are disrupted during pathological conditions.
Their unique properties allow each barrier to deal with specific
microenvironments and control the milieu of each tissue. Due
to the remarkable similarities of barrier properties, studies on
one barrier may provide important insight on the other barrier.
For example, study of Occludin-Claudin-based tight junction
strands in epithelial cells has led to understanding of tight junc-
tion strands in endothelial cells. Comparison of the barriers
may also be very important in understanding disease because
each barrier undergoes similar changes during pathological
inflammation. For instance, patients with IBD have a higher
incidence of MS, suggesting that these two autoimmune
diseases that affect completely different tissues actually share
similar mechanisms (Kimura et al., 2000) or common effectors.
Perhaps a critical step in the onset of each disease is breakdown
of the barrier mechanism that affords immune privilege to the
tissue.
An important point is that neither barrier functions alone, but
within the context of an organism, and thus, the function of
each barrier may influence the other. For instance, food mole-
cules that pass through the GIB into the blood stream can act
on the BBB, and CNS molecules that leave the brain can access
the GIB. Thus, it is important not only to study each barrier in
isolation, but in the context of the organisms in order to under-
stand how barriers including the BBB, GIB, skin, lung, kidney,
and others work together to maintain homeostasis. Interestingly,
both the GIB and BBB are regulated by interactions between
barrier cells with glial cells that are connected with the enteric
nervous system and the CNS, respectively. This neural coupling
may provide a unique mechanism for these barriers to talk to
each other. For instance, stress is known to influence GIB
permeability (Gareau et al., 2008) and to exacerbate symptoms
of IBS and IBD. Stress could affect mucosal barrier integrity via
the action of the enteric nervous system onmast cells, glial cells,
or enterochromaffin cells. While the effects on glial and entero-
chromaffin cells may remain local, mast cell degranulation and
activation could lead to a systemic inflammatory response that
could affect the permeability of the BBB. As mentioned above,
mast cells are located on the brain side of the BBB and are
ensheathed by astrocytes but, if activated, can also penetrate
the BBB of adult rats (Silverman et al., 2000). Hence, under
stress conditions, mast cells may migrate into the brain and
participate to altered BBB permeability. What could be the
consequences of an altered GIB and BBB? An interesting hypo-
thesis has been recently proposed (Theoharides et al., 2008).
A correlation between children with autistic spectrum disorders
and anxiety, allergy, or food intolerance has been observed.
Becuase mast cells can mediate allergic disorders and respond
to stress, it was suggested that mast cells may mediate neuroin-
flammation and increased BBB permeability.
Thus, understanding the mechanisms that control the forma-
tion and function of each barrier, their interrelationship, and
how pathogens evade them, may provide new insight into
complex behavioral diseases and new targets for therapeutics
to control infectious diseases.
Immunity
ReviewACKNOWLEDGMENTS
M.R. is supported by the Crohn’s and Colitis Foundation of America (CCFA), by
the European Research Council (ERC), by the European Commission (FP7:
IBDase, MetaHIT), and by the Italian Association for Cancer Research
(AIRC). R.D. is supported by the Sandler Foundation and the Myelin Repair
Foundation.
REFERENCES
Acloque, H., Adams, M.S., Fishwick, K., Bronner-Fraser, M., and Nieto, M.A.
(2009). Epithelial-mesenchymal transitions: the importance of changing cell
state in development and disease. J. Clin. Invest. 119, 1438–1449.
Aird, W.C. (2007). Phenotypic heterogeneity of the endothelium: I. Structure,
function, and mechanisms. Circ. Res. 100, 158–173.
Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W., and Rossi, F.M. (2007). Local
self-renewal can sustain CNS microglia maintenance and function throughout
adult life. Nat. Neurosci. 10, 1538–1543.
Arques, J.L., Hautefort, I., Ivory, K., Bertelli, E., Regoli, M., Clare, S., Hinton,
J.C., and Nicoletti, C. (2009). Salmonella induces Flagellin- and MyD88-
dependent migration of bacteria-capturing dendritic cells into the gut lumen.
Gastroenterology 137, 415–418.
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M.,
Yagita, H., Ishii, N., Evans, R., Honda, K., and Takeda, K. (2008). ATP drives
lamina propria T(H)17 cell differentiation. Nature 455, 808–812.
Atuma, C., Strugala, V., Allen, A., and Holm, L. (2001). The adherent gastroin-
testinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol.
Gastrointest. Liver Physiol. 280, G922–G929.
Bailey, S.L., Schreiner, B., McMahon, E.J., and Miller, S.D. (2007). CNS
myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize
CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8, 172–180.
Ballabh, P., Braun, A., and Nedergaard, M. (2004). The blood-brain barrier: an
overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16,
1–13.
Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G., and Janeway, C.A., Jr.
(1993). Surface expression of alpha 4 integrin by CD4 T cells is required for
their entry into brain parenchyma. J. Exp. Med. 177, 57–68.
Bauer, H.C., Bauer, H., Lametschwandtner, A., Amberger, A., Ruiz, P., and
Steiner, M. (1993). Neovascularization and the appearance of morphological
characteristics of the blood-brain barrier in the embryonic mouse central
nervous system. Brain Res. Dev. Brain Res. 75, 269–278.
Behling-Kelly, E., Vonderheid, H., Kim, K.S., Corbeil, L.B., and Czuprynski,
C.J. (2006). Roles of cellular activation and sulfated glycans in Haemophilus
somnus adherence to bovine brain microvascular endothelial cells. Infect.
Immun. 74, 5311–5318.
Belkaid, Y., and Tarbell, K. (2009). Regulatory T cells in the control of host-
microorganism interactions (*). Annu. Rev. Immunol. 27, 551–589.
Berkes, J., Viswanathan, V.K., Savkovic, S.D., and Hecht, G. (2003). Intestinal
epithelial responses to enteric pathogens: effects on the tight junction barrier,
ion transport, and inflammation. Gut 52, 439–451.
Bowes, M.P., Zivin, J.A., and Rothlein, R. (1993). Monoclonal antibody to the
ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embo-
lism stroke model. Exp. Neurol. 119, 215–219.
Buckner, C.M., Luers, A.J., Calderon, T.M., Eugenin, E.A., and Berman, J.W.
(2006). Neuroimmunity and the blood-brain barrier: molecular regulation of
leukocyte transmigration and viral entry into the nervous system with a focus
on neuroAIDS. J. Neuroimmune Pharmacol. 1, 160–181.
Bullard, D.C., Hu, X., Schoeb, T.R., Collins, R.G., Beaudet, A.L., and Barnum,
S.R. (2007). Intercellular adhesion molecule-1 expression is required on
multiple cell types for the development of experimental autoimmune enceph-
alomyelitis. J. Immunol. 178, 851–857.
Bush, T.G., Savidge, T.C., Freeman, T.C., Cox, H.J., Campbell, E.A., Mucke,
L., Johnson, M.H., and Sofroniew, M.V. (1998). Fulminant jejuno-ileitis
following ablation of enteric glia in adult transgenic mice. Cell 93, 189–201.Carson, M.J., Doose, J.M., Melchior, B., Schmid, C.D., and Ploix, C.C. (2006).
CNS immune privilege: hiding in plain sight. Immunol. Rev. 213, 48–65.
Cash, H.L., Whitham, C.V., Behrendt, C.L., and Hooper, L.V. (2006). Symbiotic
bacteria direct expression of an intestinal bactericidal lectin. Science 313,
1126–1130.
Cayrol, R., Wosik, K., Berard, J.L., Dodelet-Devillers, A., Ifergan, I., Kebir, H.,
Haqqani, A.S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008). Activated
leukocyte cell adhesion molecule promotes leukocyte trafficking into the
central nervous system. Nat. Immunol. 9, 137–145.
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., Doherty,
J.M., Mills, J.C., and Colonna, M. (2009). A human natural killer cell subset
provides an innate source of IL-22 formucosal immunity. Nature 457, 722–725.
Cenac, N., Chin, A.C., Garcia-Villar, R., Salvador-Cartier, C., Ferrier, L., Verg-
nolle, N., Buret, A.G., Fioramonti, J., and Bueno, L. (2004). PAR2 activation
alters colonic paracellular permeability in mice via IFN-gamma-dependent
and -independent pathways. J. Physiol. 558, 913–925.
Cerutti, A., and Rescigno, M. (2008). The biology of intestinal immunoglobulin
A responses. Immunity 28, 740–750.
Chadwick, V.S., Mellor, D.M., Myers, D.B., Selden, A.C., Keshavarzian, A.,
Broom, M.F., and Hobson, C.H. (1988). Production of peptides inducing
chemotaxis and lysosomal enzyme release in human neutrophils by intestinal
bacteria in vitro and in vivo. Scand. J. Gastroenterol. 23, 121–128.
Charlier, C., Nielsen, K., Daou, S., Brigitte, M., Chretien, F., and Dromer, F.
(2009). Evidence of a role for monocytes in dissemination and brain invasion
by Cryptococcus neoformans. Infect. Immun. 77, 120–127.
Chung, J.W., Hong, S.J., Kim, K.J., Goti, D., Stins, M.F., Shin, S., Dawson, V.L.,
Dawson, T.M., and Kim, K.S. (2003). 37-kDa laminin receptor precursor modu-
lates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial
uptake. J. Biol. Chem. 278, 16857–16862.
Colegio, O.R., Van Itallie, C., Rahner, C., and Anderson, J.M. (2003). Claudin
extracellular domains determine paracellular charge selectivity and resistance
but not tight junction fibril architecture. Am. J. Physiol. Cell Physiol. 284,
C1346–C1354.
Connolly, E.S., Jr., Winfree, C.J., Springer, T.A., Naka, Y., Liao, H., Yan, S.D.,
Stern, D.M., Solomon, R.A., Gutierrez-Ramos, J.C., and Pinsky, D.J. (1996).
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral
artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.
J. Clin. Invest. 97, 209–216.
Cornet, A., Savidge, T.C., Cabarrocas, J., Deng, W.L., Colombel, J.F., Lass-
mann, H., Desreumaux, P., and Liblau, R.S. (2001). Enterocolitis induced by
autoimmune targeting of enteric glial cells: a possible mechanism in Crohn’s
disease? Proc. Natl. Acad. Sci. USA 98, 13306–13311.
Correale, J., and Villa, A. (2007). The blood-brain-barrier in multiple sclerosis:
functional roles and therapeutic targeting. Autoimmunity 40, 148–160.
Corthesy, B. (2007). Roundtrip Ticket for Secretory IgA: Role in Mucosal
Homeostasis? J. Immunol. 178, 27–32.
Cossart, P., and Sansonetti, P.J. (2004). Bacterial invasion: the paradigms of
enteroinvasive pathogens. Science 304, 242–248.
Coureuil, M., Mikaty, G., Miller, F., Lecuyer, H., Bernard, C., Bourdoulous, S.,
Dumenil, G., Mege, R.M., Weksler, B.B., Romero, I.A., et al. (2009). Meningo-
coccal type IV pili recruit the polarity complex to cross the brain endothelium.
Science 325, 83–87.
Crowther, R.S., Roomi, N.W., Fahim, R.E., and Forstner, J.F. (1987). Vibrio
cholerae metalloproteinase degrades intestinal mucin and facilitates entero-
toxin-induced secretion from rat intestine. Biochim. Biophys. Acta 924,
393–402.
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C.J., and Barres, B.A.
(2009). Wnt/beta-catenin signaling is required for CNS, but not non-CNS,
angiogenesis. Proc. Natl. Acad. Sci. USA 106, 641–646.
Dawicki, W., and Marshall, J.S. (2007). New and emerging roles for mast cells
in host defence. Curr. Opin. Immunol. 19, 31–38.
De Jager, P.L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Lan-
gelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A., et al. (2007). TheImmunity 31, November 20, 2009 ª2009 Elsevier Inc. 731
Immunity
Reviewrole of the Toll receptor pathway in susceptibility to inflammatory bowel
diseases. Genes Immun. 8, 387–397.
de Repentigny, L., Aumont, F., Bernard, K., and Belhumeur, P. (2000). Charac-
terization of binding of Candida albicans to small intestinal mucin and its role in
adherence to mucosal epithelial cells. Infect. Immun. 68, 3172–3179.
Dehouck, M.P., Meresse, S., Delorme, P., Fruchart, J.C., and Cecchelli, R.
(1990). An easier, reproducible, and mass-production method to study the
blood-brain barrier in vitro. J. Neurochem. 54, 1798–1801.
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio,
P., Marmon, S., Sutton, R.E., Hill, C.M., et al. (1996). Identification of a major
co-receptor for primary isolates of HIV-1. Nature 381, 661–666.
Denning, T.L., Wang, Y.C., Patel, S.R., Williams, I.R., and Pulendran, B. (2007).
Lamina propria macrophages and dendritic cells differentially induce regu-
latory and interleukin 17-producing T cell responses. Nat. Immunol. 8,
1086–1094.
Di Santo, J.P., and Vosshenrich, C.A. (2006). Bone marrow versus thymic
pathways of natural killer cell development. Immunol. Rev. 214, 35–46.
Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M.,
Tsuruo, T., Sawada, Y., Niwa, M., and Kataoka, Y. (2005). Brain pericytes
contribute to the induction and up-regulation of blood-brain barrier functions
through transforming growth factor-beta production. Brain Res. 1038,
208–215.
Dubin, P.J., and Kolls, J.K. (2008). Th17 cytokines and mucosal immunity.
Immunol. Rev. 226, 160–171.
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K., and Meyer zum
Buschenfelde, K.H. (1995). Tolerance exists towards resident intestinal flora
but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol.
102, 448–455.
Dunlop, S.P., Hebden, J., Campbell, E., Naesdal, J., Olbe, L., Perkins, A.C.,
and Spiller, R.C. (2006). Abnormal intestinal permeability in subgroups of diar-
rhea-predominant irritable bowel syndromes. Am. J. Gastroenterol. 101,
1288–1294.
Ek, C.J., Dziegielewska, K.M., Stolp, H., and Saunders, N.R. (2006). Functional
effectiveness of the blood-brain barrier to small water-soluble molecules in
developing and adult opossum (Monodelphis domestica). J. Comp. Neurol.
496, 13–26.
Engelhardt, B. (2006). Molecular mechanisms involved in T cell migration
across the blood-brain barrier. J. Neural Transm. 113, 477–485.
Engelhardt, B. (2008). Immune cell entry into the central nervous system:
involvement of adhesion molecules and chemokines. J. Neurol. Sci. 274,
23–26.
Ewaschuk, J.B., Tejpar, Q.Z., Soo, I., Madsen, K., and Fedorak, R.N. (2006).
The role of antibiotic and probiotic therapies in current and futuremanagement
of inflammatory bowel disease. Curr. Gastroenterol. Rep. 8, 486–498.
Farhadi, A., Fields, J.Z., and Keshavarzian, A. (2007). Mucosal mast cells are
pivotal elements in inflammatory bowel disease that connect the dots: stress,
intestinal hyperpermeability and inflammation. World J. Gastroenterol. 13,
3027–3030.
Fleeton, M.N., Contractor, N., Leon, F., Wetzel, J.D., Dermody, T.S., and Kel-
sall, B.L. (2004). Peyer’s patch dendritic cells process viral antigen from
apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp.
Med. 200, 235–245.
Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot,
T., Quertinmont, E., Abramowicz, M., Van Gossum, A., Deviere, J., and
Rutgeerts, P. (2004). Deficient host-bacteria interactions in inflammatory
bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is
associated with Crohn’s disease and ulcerative colitis. Gut 53, 987–992.
Fukudo, S. (2007). Role of corticotropin-releasing hormone in irritable bowel
syndrome and intestinal inflammation. J. Gastroenterol. 42 (Suppl 17), 48–51.
Gareau, M.G., Silva, M.A., and Perdue, M.H. (2008). Pathophysiological mech-
anisms of stress-induced intestinal damage. Curr. Mol. Med. 8, 274–281.
Gastaldelli, M., Imelli, N., Boucke, K., Amstutz, B., Meier, O., and Greber, U.F.
(2008). Infectious adenovirus type 2 transport through early but not late endo-
somes. Traffic 9, 2265–2278.732 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.Gloor, S.M., Wachtel, M., Bolliger, M.F., Ishihara, H., Landmann, R., and Frei,
K. (2001). Molecular and cellular permeability control at the blood-brain barrier.
Brain Res. Rev. 36, 258–264.
Grab, D.J., Nikolskaia, O., Kim, Y.V., Lonsdale-Eccles, J.D., Ito, S., Hara, T.,
Fukuma, T., Nyarko, E., Kim, K.J., Stins, M.F., et al. (2004). African trypano-
some interactions with an in vitro model of the human blood-brain barrier.
J. Parasitol. 90, 970–979.
Grab, D.J., Perides, G., Dumler, J.S., Kim, K.J., Park, J., Kim, Y.V., Nikolskaia,
O., Choi, K.S., Stins, M.F., and Kim, K.S. (2005). Borrelia burgdorferi, host-
derived proteases, and the blood-brain barrier. Infect. Immun. 73, 1014–1022.
Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer,
T., Noelle, R.J., and Becher, B. (2005). Dendritic cells permit immune invasion
of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328–334.
Hampe, J., Cuthbert, A., Croucher, P.J., Mirza, M.M., Mascheretti, S., Fisher,
S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A.J., et al. (2001).
Association between insertion mutation in NOD2 gene and Crohn’s disease
in German and British populations. Lancet 357, 1925–1928.
Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht,
M., Mayr, G., De La Vega, F.M., Briggs, J., et al. (2007). A genome-wide asso-
ciation scan of nonsynonymous SNPs identifies a susceptibility variant for
Crohn disease in ATG16L1. Nat. Genet. 39, 207–211.
Hanani, M., and Reichenbach, A. (1994). Morphology of horseradish peroxi-
dase (HRP)-injected glial cells in the myenteric plexus of the guinea-pig. Cell
Tissue Res. 278, 153–160.
Hayashi, Y., Nomura, M., Yamagishi, S., Harada, S., Yamashita, J., and
Yamamoto, H. (1997). Induction of various blood-brain barrier properties in
non-neural endothelial cells by close apposition to co-cultured astrocytes.
Glia 19, 13–26.
Henninger, D.D., Panes, J., Eppihimer, M., Russell, J., Gerritsen, M., Ander-
son, D.C., and Granger, D.N. (1997). Cytokine-induced VCAM-1 and ICAM-1
expression in different organs of the mouse. J. Immunol. 158, 1825–1832.
Hickey, W.F., Hsu, B.L., and Kimura, H. (1991). T-lymphocyte entry into the
central nervous system. J. Neurosci. Res. 28, 254–260.
Hickey, W.F., and Kimura, H. (1988). Perivascular microglial cells of the CNS
are bone marrow-derived and present antigen in vivo. Science 239, 290–292.
Hirase, T., Staddon, J.M., Saitou, M., Ando-Akatsuka, Y., Itoh, M., Furuse, M.,
Fujimoto, K., Tsukita, S., and Rubin, L.L. (1997). Occludin as a possible
determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110,
1603–1613.
Hoffman, J.A., Badger, J.L., Zhang, Y., Huang, S.H., and Kim, K.S. (2000).
Escherichia coli K1 aslA contributes to invasion of brain microvascular endo-
thelial cells in vitro and in vivo. Infect. Immun. 68, 5062–5067.
Hori, S., Ohtsuki, S., Hosoya, K., Nakashima, E., and Terasaki, T. (2004).
A pericyte-derived angiopoietin-1 multimeric complex induces occludin
gene expression in brain capillary endothelial cells through Tie-2 activation
in vitro. J. Neurochem. 89, 503–513.
Huang, J., Upadhyay, U.M., and Tamargo, R.J. (2006). Inflammation in stroke
and focal cerebral ischemia. Surg. Neurol. 66, 232–245.
Huang, S.H., Chen, Y.H., Fu, Q., Stins, M., Wang, Y., Wass, C., and Kim, K.S.
(1999). Identification and characterization of an Escherichia coli invasion gene
locus, ibeB, required for penetration of brain microvascular endothelial cells.
Infect. Immun. 67, 2103–2109.
Huang, S.H., Wass, C., Fu, Q., Prasadarao, N.V., Stins, M., and Kim, K.S.
(1995). Escherichia coli invasion of brain microvascular endothelial cells
in vitro and in vivo: molecular cloning and characterization of invasion gene
ibe10. Infect. Immun. 63, 4470–4475.
Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J.,
Almer, S., Tysk, C., O’Morain, C.A., Gassull, M., et al. (2001). Association of
NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease.
Nature 411, 599–603.
Ibrahim, M.Z., Koshayan, D.S., and Khreis, Y.M. (1980). The mast cells of the
mammalian central nervous system. VI. Uptake of tritiated thymidine by mast
cells, neurolipomastocytoid cells and other elements of the central nervous
system. Acta Anat. (Basel) 108, 102–114.
Immunity
ReviewIfergan, I., Kebir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R.,
Arbour, N., and Prat, A. (2008). The blood-brain barrier induces differentiation
of migrating monocytes into Th17-polarizing dendritic cells. Brain 131,
785–799.
Iliev, I.D., Mileti, E., Matteoli, G., Chieppa, M., and Rescigno, M. (2009a). Intes-
tinal epithelial cells promote colitis-protective regulatory T-cell differentiation
through dendritic cell conditioning. Mucosal Immunol. 2, 340–350.
Iliev, I.D., Spadoni, I., Mileti, E., Matteoli, G., Sonzogni, A., Sampietro, G.M.,
Foschi, D., Caprioli, F., Viale, G., and Rescigno, M. (2009b). Human intestinal
epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut, in
press. Published online June 30, 2009. gut.2008.175166v1.
Ismail, A.S., Behrendt, C.L., and Hooper, L.V. (2009). Reciprocal interactions
between commensal bacteria and gamma delta intraepithelial lymphocytes
during mucosal injury. J. Immunol. 182, 3047–3054.
Isobe, I., Watanabe, T., Yotsuyanagi, T., Hazemoto, N., Yamagata, K., Ueki, T.,
Nakanishi, K., Asai, K., and Kato, T. (1996). Astrocytic contributions to blood-
brain barrier (BBB) formation by endothelial cells: a possible use of aortic
endothelial cell for in vitro BBB model. Neurochem. Int. 28, 523–533.
Iweala, O.I., and Nagler, C.R. (2006). Immune privilege in the gut: the establish-
ment and maintenance of non-responsiveness to dietary antigens and
commensal flora. Immunol. Rev. 213, 82–100.
Jang,M.H., Kweon, M.N., Iwatani, K., Yamamoto,M., Terahara, K., Sasakawa,
C., Suzuki, T., Nochi, T., Yokota, Y., Rennert, P.D., et al. (2004). Intestinal
villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl.
Acad. Sci. USA 101, 6110–6115.
Janzer, R.C., and Raff, M.C. (1987). Astrocytes induce blood-brain barrier
properties in endothelial cells. Nature 325, 253–257.
Johansson,M.E., Phillipson,M., Petersson, J., Velcich, A., Holm, L., and Hans-
son, G.C. (2008). The inner of the twoMuc2 mucin-dependent mucus layers in
colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064–15069.
Kanmogne, G.D., Schall, K., Leibhart, J., Knipe, B., Gendelman, H.E., and Per-
sidsky, Y. (2007). HIV-1 gp120 compromises blood-brain barrier integrity and
enhances monocyte migration across blood-brain barrier: implication for viral
neuropathogenesis. J. Cereb. Blood Flow Metab. 27, 123–134.
Kelly, D., King, T., and Aminov, R. (2007). Importance of microbial colonization
of the gut in early life to the development of immunity. Mutat. Res. 622, 58–69.
Kelsall, B. (2008). Recent progress in understanding the phenotype and func-
tion of intestinal dendritic cells and macrophages. Mucosal Immunol. 1,
460–469.
Khan, N.A., Kim, Y., Shin, S., and Kim, K.S. (2007). FimH-mediated Escherichia
coli K1 invasion of human brainmicrovascular endothelial cells. Cell. Microbiol.
9, 169–178.
Kim, K.S. (2008). Mechanisms of microbial traversal of the blood-brain barrier.
Nat. Rev. Microbiol. 6, 625–634.
Kim, K.S., Itabashi, H., Gemski, P., Sadoff, J., Warren, R.L., and Cross, A.S.
(1992). The K1 capsule is the critical determinant in the development of
Escherichia coli meningitis in the rat. J. Clin. Invest. 90, 897–905.
Kimura, K., Hunter, S.F., Thollander, M.S., Loftus, E.V., Jr., Melton, L.J., III,
O’Brien, P.C., Rodriguez, M., and Phillips, S.F. (2000). Concurrence of inflam-
matory bowel disease and multiple sclerosis. Mayo Clin. Proc. 75, 802–806.
Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N.,
Nunez, G., and Flavell, R.A. (2005). Nod2-dependent regulation of innate
and adaptive immunity in the intestinal tract. Science 307, 731–734.
Komano, H., Fujiura, Y., Kawaguchi, M., Matsumoto, S., Hashimoto, Y.,
Obana, S., Mombaerts, P., Tonegawa, S., Yamamoto, H., Itohara, S., et al.
(1995). Homeostatic regulation of intestinal epithelia by intraepithelial gamma
delta T cells. Proc. Natl. Acad. Sci. USA 92, 6147–6151.
Kunisawa, J., Takahashi, I., and Kiyono, H. (2007). Intraepithelial lymphocytes:
their shared and divergent immunological behaviors in the small and large
intestine. Immunol. Rev. 215, 136–153.
Laschinger, M., and Engelhardt, B. (2000). Interaction of alpha4-integrin with
VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endo-
thelium but not in their transendothelial migration in vitro. J. Neuroimmunol.
102, 32–43.Lee, J., Mo, J.H., Katakura, K., Alkalay, I., Rucker, A.N., Liu, Y.T., Lee, H.K.,
Shen, C., Cojocaru, G., Shenouda, S., et al. (2006). Maintenance of colonic
homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells.
Nat. Cell Biol. 8, 1327–1336.
Lee, K.J., Kim, Y.B., Kim, J.H., Kwon, H.C., Kim, D.K., and Cho, S.W. (2008).
The alteration of enterochromaffin cell, mast cell, and lamina propria T lympho-
cyte numbers in irritable bowel syndrome and its relationship with psycholog-
ical factors. J. Gastroenterol. Hepatol. 23, 1689–1694.
Lee, S.W., Kim,W.J., Choi, Y.K., Song, H.S., Son,M.J., Gelman, I.H., Kim, Y.J.,
and Kim, K.W. (2003). SSeCKS regulates angiogenesis and tight junction
formation in blood-brain barrier. Nat. Med. 9, 900–906.
Ley, R.E., Peterson, D.A., and Gordon, J.I. (2006). Ecological and evolutionary
forces shaping microbial diversity in the human intestine. Cell 124, 837–848.
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C.J.,
Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008). Wnt/beta-catenin
signaling controls development of the blood-brain barrier. J. Cell Biol. 183,
409–417.
Linden, S.K., Sutton, P., Karlsson, N.G., Korolik, V., and McGuckin, M.A.
(2008). Mucins in the mucosal barrier to infection. Mucosal Immunol. 1,
183–197.
Luci, C., Reynders, A., Ivanov, I.I., Cognet, C., Chiche, L., Chasson, L., Hard-
wigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. (2009). Influ-
ence of the transcription factor RORgammat on the development of NKp46+
cell populations in gut and skin. Nat. Immunol. 10, 75–82.
Lyck, R., Reiss, Y., Gerwin, N., Greenwood, J., Adamson, P., and Engelhardt,
B. (2003). T-cell interaction with ICAM-1/ICAM-2 double-deficient brain
endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary
for transendothelial migration of T cells. Blood 102, 3675–3683.
Macfarlane, S., and Dillon, J.F. (2007). Microbial biofilms in the human gastro-
intestinal tract. J. Appl. Microbiol. 102, 1187–1196.
Macpherson, A.J., McCoy, K.D., Johansen, F.E., and Brandtzaeg, P. (2008).
The immune geography of IgA induction and function. Mucosal Immunol. 1,
11–22.
Mark, K.S., and Davis, T.P. (2002). Cerebral microvascular changes in perme-
ability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol.
Heart Circ. Physiol. 282, H1485–H1494.
Maroof, A., Beattie, L., Zubairi, S., Svensson, M., Stager, S., and Kaye, P.M.
(2008). Posttranscriptional regulation of II10 gene expression allows natural
killer cells to express immunoregulatory function. Immunity 29, 295–305.
Marshall, J.S. (2004). Mast-cell responses to pathogens. Nat. Rev. Immunol. 4,
787–799.
Mayadas, T.N., Johnson, R.C., Rayburn, H., Hynes, R.O., and Wagner, D.D.
(1993). Leukocyte rolling and extravasation are severely compromised in P
selectin-deficient mice. Cell 74, 541–554.
McGovern, D.P., Hysi, P., Ahmad, T., van Heel, D.A., Moffatt, M.F., Carey, A.,
Cookson, W.O., and Jewell, D.P. (2005). Association between a complex
insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to
inflammatory bowel disease. Hum. Mol. Genet. 14, 1245–1250.
Moncada, D., Yu, Y., Keller, K., and Chadee, K. (2000). Entamoeba histolytica
cysteine proteinases degrade human colonic mucin and alter its function.
Arch. Med. Res. 31, S224–S225.
Mora, J.R., Iwata, M., and von Andrian, U.H. (2008). Vitamin effects on the
immune system: vitamins A and D take centre stage. Nat. Rev. Immunol., in
press. Published online August 8, 2008. 10.1038/nri2378.
Morita, K., Sasaki, H., Furuse, M., and Tsukita, S. (1999). Endothelial claudin:
claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell
Biol. 147, 185–194.
Motomura, Y., Ghia, J.E., Wang, H., Akiho, H., El-Sharkawy, R.T., Collins, M.,
Wan, Y., McLaughlin, J.T., and Khan, W.I. (2008). Enterochromaffin cell and
5-hydroxytryptamine responses to the same infectious agent differ in Th1
and Th2 dominant environments. Gut 57, 475–481.
Mueller, C.A., Broz, P., and Cornelis, G.R. (2008). The type III secretion system
tip complex and translocon. Mol. Microbiol. 68, 1085–1095.Immunity 31, November 20, 2009 ª2009 Elsevier Inc. 733
Immunity
ReviewNautiyal, K.M., Ribeiro, A.C., Pfaff, D.W., and Silver, R. (2008). Brain mast cells
link the immune system to anxiety-like behavior. Proc. Natl. Acad. Sci. USA
105, 18053–18057.
Neunlist, M., Aubert, P., Bonnaud, S., Van Landeghem, L., Coron, E., Wedel,
T., Naveilhan, P., Ruhl, A., Lardeux, B., Savidge, T., et al. (2007). Enteric glia
inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-depen-
dent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G231–G241.
Neunlist, M., Van Landeghem, L., Bourreille, A., and Savidge, T. (2008). Neuro-
glial crosstalk in inflammatory bowel disease. J. Intern. Med. 263, 577–583.
Neutra, M.R., Pringault, E., and Kraehenbuhl, J.P. (1996). Antigen sampling
across epithelial barriers and induction of mucosal immune responses.
Annu. Rev. Immunol. 14, 275–300.
Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas,
J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. (2005). CX3CR1-Mediated
Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance. Science
307, 254–258.
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M.,
and Tsukita, S. (2003). Size-selective loosening of the blood-brain barrier in
claudin-5-deficient mice. J. Cell Biol. 161, 653–660.
Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Brit-
ton, H., Moran, T., Karaliuskas, R., Duerr, R.H., et al. (2001). A frameshift muta-
tion in NOD2 associated with susceptibility to Crohn’s disease. Nature 411,
603–606.
Orihuela, C.J., Mahdavi, J., Thornton, J., Mann, B., Wooldridge, K.G., Abou-
seada, N., Oldfield, N.J., Self, T., Ala’aldeen, D.A., and Tuomanen, E.I.
(2009). Laminin receptor initiates bacterial contact with the blood brain barrier
in experimental meningitis models. J. Clin. Invest. 119, 1638–1646.
Polfliet, M.M., Zwijnenburg, P.J., van Furth, A.M., van der Poll, T., Dopp, E.A.,
Renardel de Lavalette, C., van Kesteren-Hendrikx, E.M., van Rooijen, N., Dijk-
stra, C.D., and van den Berg, T.K. (2001). Meningeal and perivascular macro-
phages of the central nervous system play a protective role during bacterial
meningitis. J. Immunol. 167, 4644–4650.
Polman, C.H., O’Connor, P.W., Havrdova, E., Hutchinson, M., Kappos, L.,
Miller, D.H., Phillips, J.T., Lublin, F.D., Giovannoni, G., Wajgt, A., et al.
(2006). A randomized, placebo-controlled trial of natalizumab for relapsing
multiple sclerosis. N. Engl. J. Med. 354, 899–910.
Prasadarao, N.V., Wass, C.A., Stins, M.F., Shimada, H., and Kim, K.S. (1999).
Outer membrane protein A-promoted actin condensation of brain microvas-
cular endothelial cells is required for Escherichia coli invasion. Infect. Immun.
67, 5775–5783.
Prasadarao, N.V., Srivastava, P.K., Rudrabhatla, R.S., Kim, K.S., Huang, S.H.,
and Sukumaran, S.K. (2003). Cloning and expression of the Escherichia coli K1
outer membrane protein A receptor, a gp96 homologue. Infect. Immun. 71,
1680–1688.
Raybould, H.E. (2008). Nutrient sensing in the gastrointestinal tract: possible
role for nutrient transporters. J. Physiol. Biochem. 64, 349–356.
Reijerkerk, A., Kooij, G., van der Pol, S.M., Khazen, S., Dijkstra, C.D., and de
Vries, H.E. (2006). Diapedesis of monocytes is associatedwithMMP-mediated
occludin disappearance in brain endothelial cells. FASEB J. 20, 2550–2552.
Reijerkerk, A., Kooij, G., van der Pol, S.M., Leyen, T., van Het Hof, B., Couraud,
P.O., Vivien, D., Dijkstra, C.D., and de Vries, H.E. (2008). Tissue-type plasmin-
ogen activator is a regulator of monocyte diapedesis through the brain endo-
thelial barrier. J. Immunol. 181, 3567–3574.
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R.,
Granucci, F., Kraehenbuhl, J.P., and Ricciardi-Castagnoli, P. (2001). Dendritic
cells express tight junction proteins and penetrate gut epithelial monolayers to
sample bacteria. Nat. Immunol. 2, 361–367.
Rescigno, M., Lopatin, U., and Chieppa, M. (2008). Interactions among
dendritic cells, macrophages, and epithelial cells in the gut: implications for
immune tolerance. Curr. Opin. Immunol. 20, 669–675.
Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro,
G.M., Nespoli, A., Viale, G., Allavena, P., and Rescigno, M. (2005). Intestinal
immune homeostasis is regulated by the crosstalk between epithelial cells
and dendritic cells. Nat. Immunol. 6, 507–514.734 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.Robbe, C., Capon, C., Coddeville, B., and Michalski, J.C. (2004). Structural
diversity and specific distribution of O-glycans in normal human mucins along
the intestinal tract. Biochem. J. 384, 307–316.
Rubin, L.L., and Staddon, J.M. (1999). The cell biology of the blood-brain
barrier. Annu. Rev. Neurosci. 22, 11–28.
Rubin, L.L., Hall, D.E., Porter, S., Barbu, K., Cannon, C., Horner, H.C., Janat-
pour, M., Liaw, C.W., Manning, K., Morales, J., et al. (1991). A cell culture
model of the blood-brain barrier. J. Cell Biol. 115, 1725–1735.
Saitoh, T., Fujita, N., Jang,M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H.,
Noda, T., Yamamoto, N., Komatsu, M., et al. (2008). Loss of the autophagy
protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature
456, 264–268.
Saitou, M., Furuse, M., Sasaki, H., Schulzke, J.D., Fromm, M., Takano, H.,
Noda, T., and Tsukita, S. (2000). Complex phenotype of mice lacking occludin,
a component of tight junction strands. Mol. Biol. Cell 11, 4131–4142.
Sandoval, K.E., andWitt, K.A. (2008). Blood-brain barrier tight junction perme-
ability and ischemic stroke. Neurobiol. Dis. 32, 200–219.
Sanos, S.L., Bui, V.L., Mortha, A., Oberle, K., Heners, C., Johner, C., and Die-
fenbach, A. (2009). RORgammat and commensal microflora are required for
the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat.
Immunol. 10, 83–91.
Sansonetti, P.J. (2004). War and peace at mucosal surfaces. Nat. Rev. Immu-
nol. 4, 953–964.
Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Loch-
ner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N., Mandelboim,
O., et al. (2008). Microbial flora drives interleukin 22 production in intestinal
NKp46+ cells that provide innate mucosal immune defense. Immunity 29,
958–970.
Savidge, T.C., Newman, P., Pothoulakis, C., Ruhl, A., Neunlist, M., Bourreille,
A., Hurst, R., and Sofroniew, M.V. (2007). Enteric glia regulate intestinal barrier
function and inflammation via release of S-nitrosoglutathione. Gastroenter-
ology 132, 1344–1358.
Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van
Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele,
H.P., et al. (1994). Disruption of themousemdr1a P-glycoprotein gene leads to
a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell
77, 491–502.
Schinkel, A.H., Wagenaar, E., Mol, C.A., and van Deemter, L. (1996). P-glyco-
protein in the blood-brain barrier of mice influences the brain penetration and
pharmacological activity of many drugs. J. Clin. Invest. 97, 2517–2524.
Shen, L., and Turner, J.R. (2006). Role of epithelial cells in initiation and propa-
gation of intestinal inflammation. Eliminating the static: tight junction dynamics
exposed. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G577–G582.
Shen, L., Weber, C.R., and Turner, J.R. (2008). The tight junction protein
complex undergoes rapid and continuous molecular remodeling at steady
state. J. Cell Biol. 181, 683–695.
Silverman, A.J., Sutherland, A.K., Wilhelm, M., and Silver, R. (2000). Mast cells
migrate from blood to brain. J. Neurosci. 20, 401–408.
Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G.,
Benjamin, W.H., Orenstein, J.M., and Smith, P.D. (2005). Human intestinal
macrophages display profound inflammatory anergy despite avid phagocytic
and bacteriocidal activity. J. Clin. Invest. 115, 66–75.
Sonnenburg, J.L., Angenent, L.T., and Gordon, J.I. (2004). Getting a grip on
things: how do communities of bacterial symbionts become established in
our intestine? Nat. Immunol. 5, 569–573.
Spiller, R. (2008). Serotonin and GI clinical disorders. Neuropharmacology 55,
1072–1080.
Stead, R.H., Tomioka, M., Quinonez, G., Simon, G.T., Felten, S.Y., and Bienen-
stock, J. (1987). Intestinal mucosal mast cells in normal and nematode-
infected rat intestines are in intimate contact with peptidergic nerves. Proc.
Natl. Acad. Sci. USA 84, 2975–2979.
Steffen, B.J., Butcher, E.C., and Engelhardt, B. (1994). Evidence for involve-
ment of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in
Immunity
Reviewexperimental autoimmune encephalomyelitis in the central nervous system in
the SJL/J mouse. Am. J. Pathol. 145, 189–201.
Steinhoff, M., Vergnolle, N., Young, S.H., Tognetto, M., Amadesi, S., Ennes,
H.S., Trevisani, M., Hollenberg, M.D., Wallace, J.L., Caughey, G.H., et al.
(2000). Agonists of proteinase-activated receptor 2 induce inflammation by
a neurogenic mechanism. Nat. Med. 6, 151–158.
Stenman, J.M., Rajagopal, J., Carroll, T.J., Ishibashi, M., McMahon, J., and
McMahon, A.P. (2008). Canonical Wnt signaling regulates organ-specific
assembly and differentiation of CNS vasculature. Science 322, 1247–1250.
Stent, G., and Crowe, S.M. (1997). Effects of HIV-1 on the surface expression
of LFA-1 on cultured monocytes. J. Acquir. Immune Defic. Syndr. Hum. Retro-
virol. 15, 95–103.
Stewart, P.A., and Wiley, M.J. (1981). Developing nervous tissue induces
formation of blood-brain barrier characteristics in invading endothelial cells:
a study using quail–chick transplantation chimeras. Dev. Biol. 84, 183–192.
Streit, W.J., Conde, J.R., Fendrick, S.E., Flanary, B.E., and Mariani, C.L.
(2005). Role of microglia in the central nervous system’s immune response.
Neurol. Res. 27, 685–691.
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and
Belkaid, Y. (2007). Small intestine lamina propria dendritic cells promote
de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204,
1775–1785.
Teng, C.H., Cai, M., Shin, S., Xie, Y., Kim, K.J., Khan, N.A., Di Cello, F., and
Kim, K.S. (2005). Escherichia coli K1 RS218 interacts with human brain micro-
vascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.
Infect. Immun. 73, 2923–2931.
Teng, C.H., Xie, Y., Shin, S., Di Cello, F., Paul-Satyaseela, M., Cai, M., and Kim,
K.S. (2006). Effects of ompA deletion on expression of type 1 fimbriae in
Escherichia coli K1 strain RS218 and on the association of E. coli with human
brain microvascular endothelial cells. Infect. Immun. 74, 5609–5616.
Theoharides, T.C., Doyle, R., Francis, K., Conti, P., and Kalogeromitros, D.
(2008). Novel therapeutic targets for autism. Trends Pharmacol. Sci. 29,
375–382.
Turksen, K., and Troy, T.C. (2004). Barriers built on claudins. J. Cell Sci. 117,
2435–2447.
Turville, S.G., Cameron, P.U., Handley, A., Lin, G., Pohlmann, S., Doms, R.W.,
and Cunningham, A.L. (2002). Diversity of receptors binding HIV on dendritic
cell subsets. Nat. Immunol. 3, 975–983.
Unger, E.R., Sung, J.H., Manivel, J.C., Chenggis, M.L., Blazar, B.R., and Krivit,
W. (1993). Male donor-derived cells in the brains of female sex-mismatched
bone marrow transplant recipients: a Y-chromosome specific in situ hybrid-
ization study. J. Neuropathol. Exp. Neurol. 52, 460–470.
Vaishnava, S., Behrendt, C.L., Ismail, A.S., Eckmann, L., and Hooper, L.V.
(2008). Paneth cells directly sense gut commensals and maintain homeostasis
at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 105,
20858–20863.
Van Teeffelen, J.W., Brands, J., Stroes, E.S., and Vink, H. (2007). Endothelial
glycocalyx: sweet shield of blood vessels. Trends Cardiovasc. Med. 17,
101–105.
Vass, K., Hickey,W.F., Schmidt, R.E., and Lassmann, H. (1993). Bonemarrow-
derived elements in the peripheral nervous system. An immunohistochemical
and ultrastructural investigation in chimeric rats. Lab. Invest. 69, 275–282.
Vazquez-Torres, A., Jones-Carson, J., Baumler, A.J., Falkow, S., Valdivia, R.,
Brown, W., Le, M., Berggren, R., Parks, W.T., and Fang, F.C. (1999). Extrain-
testinal dissemination of Salmonella by CD18-expressing phagocytes. Nature
401, 804–808.
Vink, H., and Duling, B.R. (1996). Identification of distinct luminal domains for
macromolecules, erythrocytes, and leukocytes within mammalian capillaries.
Circ. Res. 79, 581–589.Vink, H., and Duling, B.R. (2000). Capillary endothelial surface layer selectively
reduces plasma solute distribution volume. Am. J. Physiol. Heart Circ. Physiol.
278, H285–H289.
Vivier, E., Spits, H., and Cupedo, T. (2009). Interleukin-22-producing innate
immune cells: new players in mucosal immunity and tissue repair? Nat. Rev.
Immunol. 9, 229–234.
Wallon, C., Yang, P.C., Keita, A.V., Ericson, A.C., McKay, D.M., Sherman,
P.M., Perdue, M.H., and Soderholm, J.D. (2008). Corticotropin-releasing
hormone (CRH) regulates macromolecular permeability via mast cells in
normal human colonic biopsies in vitro. Gut 57, 50–58.
Wang, H., Steeds, J., Motomura, Y., Deng, Y., Verma-Gandhu, M., El-Shar-
kawy, R.T., McLaughlin, J.T., Grencis, R.K., and Khan, W.I. (2007). CD4+
T cell-mediated immunological control of enterochromaffin cell hyperplasia
and 5-hydroxytryptamine production in enteric infection. Gut 56, 949–957.
Wang, Y., Huang, S.H., Wass, C.A., Stins, M.F., and Kim, K.S. (1999). The gene
locus yijP contributes to Escherichia coli K1 invasion of brain microvascular
endothelial cells. Infect. Immun. 67, 4751–4756.
Weidenfeller, C., Svendsen, C.N., and Shusta, E.V. (2007). Differentiating
embryonic neural progenitor cells induce blood-brain barrier properties.
J. Neurochem. 101, 555–565.
Weiner, M.L. (1988). Intestinal transport of some macromolecules in food.
Food Chem. Toxicol. 26, 867–880.
Wilhelm, M., Silver, R., and Silverman, A.J. (2005). Central nervous system
neurons acquire mast cell products via transgranulation. Eur. J. Neurosci.
22, 2238–2248.
Williams, A.E., and Blakemore, W.F. (1990). Monocyte-mediated entry of path-
ogens into the central nervous system. Neuropathol. Appl. Neurobiol. 16,
377–392.
Williams, K., Alvarez, X., and Lackner, A.A. (2001). Central nervous system
perivascular cells are immunoregulatory cells that connect the CNS with the
peripheral immune system. Glia 36, 156–164.
Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner,
S., Hamm, S., Duffner, F., Grote, E.H., Risau, W., and Engelhardt, B. (2003).
Localization of claudin-3 in tight junctions of the blood-brain barrier is
selectively lost during experimental autoimmune encephalomyelitis and
human glioblastoma multiforme. Acta Neuropathol. (Berl.) 105, 586–592.
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard,M.,Moumd-
jian, R., Bouthillier, A., Reudelhuber, T.L., and Prat, A. (2007). Angiotensin II
controls occludin function and is required for blood brain barrier maintenance:
relevance to multiple sclerosis. J. Neurosci. 27, 9032–9042.
Yamada, T., Inui, A., Hayashi, N., Fujimura, M., and Fujimiya, M. (2003). Sero-
tonin stimulates endotoxin translocation via 5–HT3 receptors in the rat ileum.
Am. J. Physiol. Gastrointest. Liver Physiol. 284, G782–G788.
Yednock, T.A., Cannon, C., Fritz, L.C., Sanchez-Madrid, F., Steinman, L., and
Karin, N. (1992). Prevention of experimental autoimmune encephalomyelitis by
antibodies against alpha 4 beta 1 integrin. Nature 356, 63–66.
Zeissig, S., Burgel, N., Gunzel, D., Richter, J., Mankertz, J., Wahnschaffe, U.,
Kroesen, A.J., Zeitz, M., Fromm, M., and Schulzke, J.D. (2007). Changes in
expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight
junctions and barrier dysfunction in active Crohn’s disease. Gut 56, 61–72.
Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas,
A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J., and Ouyang, W. (2008).
Interleukin-22 mediates early host defense against attaching and effacing
bacterial pathogens. Nat. Med. 14, 282–289.
Zlokovic, B.V. (2008). The blood-brain barrier in health and chronic neurode-
generative disorders. Neuron 57, 178–201.
Zou, Y., He, L., Wu, C.H., Cao, H., Xie, Z.H., Ouyang, Y., Wang, Y., Jong, A.,
and Huang, S.H. (2007). PSF is an IbeA-binding protein contributing to menin-
gitic Escherichia coli K1 invasion of human brain microvascular endothelial
cells. Med. Microbiol. Immunol. (Berl.) 196, 135–143.Immunity 31, November 20, 2009 ª2009 Elsevier Inc. 735
